Rick Orford - Trading Stocks and Options For All on MSN

Snowflake’s $4B AI Bet Could Send Shares Soaring

Snowflake (NYSE: SNOW) is betting $4B on AI with Cortex AI and posting 32% revenue growth. This breakdown explores its customer momentum, risks, and why the stock could surge 50% or more.
pharmaphorum

AbbVie files to move Venclexta combo into the CLL front line

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...